Sinovac Biotech Receives $500 Million in Funding for COVID-19 Vaccine Manufacturing

The company has received $500 million in funding from Sino Biopharmaceutical for further development, capacity expansion, and manufacturing of CoronaVac, its COVID-19 vaccine candidate. Sinovac Biotech, a biopharmaceutical products provider in ...

from Google Alert - Business https://ift.tt/2W04NoE
The company has received $500 million in funding from Sino Biopharmaceutical for further development, capacity expansion, and manufacturing of CoronaVac, its COVID-19 vaccine candidate. Sinovac Biotech, a biopharmaceutical products provider in ... https://ift.tt/eA8V8J

Comments

Popular posts from this blog

Jobless Rate Drops

Electrolytic Fixed Power Capacitors Market Competitive intelligence & regional outlook 2020

USU project among finalists for $3 million solar energy tech prize